Arrowhead Pharmaceuticals Stock Options Expiring on 20th of January 2023

ARWR
 Stock
  

USD 30.41  0.28  0.91%   

Arrowhead Pharmaceuticals' latest option contracts expiring on 2023-01-20 are carrying combined implied volatility of 73.22 with a put-to-call open interest ratio of 0.37 over 64 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2023-01-20. The current put volume is at 171, with calls trading at the volume of 253. This yields a 0.68 put-to-call volume ratio. The Arrowhead Pharmaceuticals option chain provides detailed quote and price information for the current Arrowhead Pharmaceuticals option contracts. It shows all of Arrowhead Pharmaceuticals' listed puts, calls, expiration dates, strike prices, and other pricing information.

Open Interest Against 2023-01-20 Option Contracts

Arrowhead Pharmaceuticals option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Arrowhead Pharmaceuticals' lending market. For example, when Arrowhead Pharmaceuticals' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Arrowhead Pharmaceuticals, he or she must hedge the risk by shorting Arrowhead Pharmaceuticals stock over its option's life.
The chart above shows Arrowhead Pharmaceuticals' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Arrowhead Pharmaceuticals' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Arrowhead Pharmaceuticals' option, there is no secondary market available for investors to trade.

Arrowhead Pharmaceuticals Maximum Pain Price across 2023-01-20 Option Contracts

Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Arrowhead Pharmaceuticals close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Arrowhead Pharmaceuticals' stock options are financial instruments that give investors the right to buy or sell shares of Arrowhead Pharmaceuticals common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Arrowhead stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Arrowhead Pharmaceuticals' stock price goes up or down, the stock options follow.
Please continue to Trending Equities.
Please note that buying 'in-the-money' options on Arrowhead Pharmaceuticals lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Arrowhead Pharmaceuticals' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Arrowhead Pharmaceuticals contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Arrowhead Stock moves the wrong way.
As of 12/09/2022, Net Income Common Stock is likely to drop to about (130.1 M)

Arrowhead Pharmaceuticals In The Money Call Balance

When Arrowhead Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Arrowhead Pharmaceuticals stock is said to be in the money. When it comes to buying Arrowhead Pharmaceuticals' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Arrowhead Pharmaceuticals are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Arrowhead Current Options Market Mood

Arrowhead Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Arrowhead Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Arrowhead Pharmaceuticals' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Arrowhead Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Arrowhead Pharmaceuticals' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Rule 16 of the current Arrowhead contract

Base on the Rule 16, the options market is currently suggesting that Arrowhead Pharmaceuticals will have an average daily up or down price movement of about 4.58% per day over the life of the 2023-01-20 option contract. With Arrowhead Pharmaceuticals trading at USD30.41, that is roughly USD1.39. If you think that the market is fully incorporating Arrowhead Pharmaceuticals' daily price movement you should consider buying Arrowhead Pharmaceuticals options at the current volatility level of 73.22%. But if you have an opposite viewpoint you should avoid it and even consider selling them.

Arrowhead Pharmaceuticals Option Chain

When Arrowhead Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Arrowhead Pharmaceuticals stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
2022-12-162023-01-202023-03-172023-06-162024-01-19
Arrowhead Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on Arrowhead. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Arrowhead. It also shows strike prices and maturity days for a Arrowhead Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
DeltaGammaOpen IntExpirationCurrent SpreadLast Price
Call
2023-01-20 CALL at $15.00.89770.0061102023-01-2014.3 - 18.916.1In
Call
2023-01-20 CALL at $17.50.95070.007902023-01-2012.0 - 16.90.0In
Call
2023-01-20 CALL at $20.00.93510.0117672023-01-209.5 - 14.312.0In
Call
2023-01-20 CALL at $23.00.90410.0196122023-01-206.7 - 11.512.6In
Call
2023-01-20 CALL at $25.00.8650.02851862023-01-205.0 - 9.56.5In
Call
2023-01-20 CALL at $28.00.74630.045432023-01-202.5 - 7.35.84In
Call
2023-01-20 CALL at $30.00.63240.04371452023-01-202.5 - 6.04.26In
Call
2023-01-20 CALL at $32.00.54060.046642023-01-202.05 - 5.03.3Out
Call
2023-01-20 CALL at $35.00.39210.04893322023-01-201.6 - 2.51.9Out
Call
2023-01-20 CALL at $37.00.30210.04571562023-01-200.8 - 1.751.3Out
Call
2023-01-20 CALL at $40.00.21190.03652852023-01-200.5 - 1.10.85Out
Call
2023-01-20 CALL at $45.00.13670.02452002023-01-200.1 - 1.00.55Out
Call
2023-01-20 CALL at $47.00.30230.0217222023-01-200.05 - 4.80.52Out
Call
2023-01-20 CALL at $70.00.04730.00744472023-01-200.05 - 0.40.4Out
 Put
2023-01-20 PUT at $25.0-0.15680.028382023-01-200.1 - 1.50.9Out
 Put
2023-01-20 PUT at $28.0-0.26740.0421762023-01-201.15 - 2.01.46Out
 Put
2023-01-20 PUT at $30.0-0.36290.05191362023-01-201.85 - 2.552.05Out
 Put
2023-01-20 PUT at $32.0-0.49020.07351552023-01-200.6 - 4.12.72In
 Put
2023-01-20 PUT at $35.0-0.62760.05267672023-01-202.85 - 7.14.5In
 Put
2023-01-20 PUT at $37.0-0.69740.045472023-01-204.3 - 9.05.66In
 Put
2023-01-20 PUT at $40.0-0.70360.0329572023-01-208.6 - 11.48.52In
 Put
2023-01-20 PUT at $42.0-0.88720.028482023-01-208.4 - 13.013.98In
 Put
2023-01-20 PUT at $45.0-0.85570.0247862023-01-2011.9 - 16.012.2In
 Put
2023-01-20 PUT at $47.0-0.95760.013212023-01-2013.3 - 17.70.0In
 Put
2023-01-20 PUT at $50.0-0.89410.0181752023-01-2016.8 - 20.818.46In
 Put
2023-01-20 PUT at $55.0-0.93940.0118632023-01-2021.3 - 25.923.6In
 Put
2023-01-20 PUT at $60.0-0.98870.003102023-01-2026.1 - 30.831.1In
 Put
2023-01-20 PUT at $65.0-0.98920.002702023-01-2031.0 - 35.930.0In
 Put
2023-01-20 PUT at $70.0-0.98950.00241182023-01-2036.0 - 40.90.0In
 Put
2023-01-20 PUT at $75.0-0.98970.0022552023-01-2041.0 - 45.942.2In
 Put
2023-01-20 PUT at $80.0-0.97390.00431532023-01-2046.1 - 50.90.0In
 Put
2023-01-20 PUT at $85.0-0.9630.005282023-01-2051.1 - 56.054.9In
 Put
2023-01-20 PUT at $90.0-0.990.001872023-01-2056.0 - 60.90.0In
 Put
2023-01-20 PUT at $95.0-0.9560.005352023-01-2061.2 - 66.00.0In
 Put
2023-01-20 PUT at $100.0-0.990.001702023-01-2066.0 - 70.90.0In
 Put
2023-01-20 PUT at $105.0-0.77870.0099202023-01-2071.0 - 75.80.0In
 Put
2023-01-20 PUT at $110.0-0.96480.004112023-01-2076.1 - 81.00.0In
 Put
2023-01-20 PUT at $115.0-0.98990.001502023-01-2081.0 - 85.90.0In
 Put
2023-01-20 PUT at $120.0-0.78430.009102023-01-2086.0 - 90.80.0In
 Put
2023-01-20 PUT at $125.0-0.98980.001402023-01-2091.1 - 95.80.0In
 Put
2023-01-20 PUT at $130.0-0.95930.00402023-01-2096.2 - 101.00.0In
 Put
2023-01-20 PUT at $135.0-0.95940.0039362023-01-20101.2 - 106.00.0In

Arrowhead Pharmaceuticals Net Income Common Stock Over Time

The amount of net income (loss) for the period due to common shareholders. Typically differs from Net Income to the parent entity due to the deduction of Preferred Dividends.
   Net Income Common Stock   
Share
       Timeline  

Arrowhead Pharmaceuticals Historical Liabilities

While analyzing the current debt level is an essential aspect of forecasting the current year budgeting needs of Arrowhead Pharmaceuticals, understanding its historical liability is critical in projecting Arrowhead Pharmaceuticals' future earnings, especially during periods of low and high inflation and deflation. Many analysts look at the trend in assets and liabilities and evaluate how Arrowhead Pharmaceuticals uses its financing power over time.

Arrowhead Pharmaceuticals Investors Sentiment

The influence of Arrowhead Pharmaceuticals' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Arrowhead. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Arrowhead Pharmaceuticals' public news can be used to forecast risks associated with investment in Arrowhead. The trend in average sentiment can be used to explain how an investor holding Arrowhead can time the market purely based on public headlines and social activities around Arrowhead Pharmaceuticals. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Arrowhead Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Arrowhead Pharmaceuticals' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Arrowhead Pharmaceuticals' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Arrowhead Pharmaceuticals.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Arrowhead Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Arrowhead Pharmaceuticals' short interest history, or implied volatility extrapolated from Arrowhead Pharmaceuticals options trading.

Pair Trading with Arrowhead Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Arrowhead Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arrowhead Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Arrowhead Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Arrowhead Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Arrowhead Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Arrowhead Pharmaceuticals to buy it.
The correlation of Arrowhead Pharmaceuticals is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Arrowhead Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Arrowhead Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Arrowhead Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to Trending Equities. You can also try Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for analysis

When running Arrowhead Pharmaceuticals price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Is Arrowhead Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arrowhead Pharmaceuticals. If investors know Arrowhead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arrowhead Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
3.3 B
Quarterly Revenue Growth YOY
(0.17) 
Return On Assets
(0.16) 
Return On Equity
(0.43) 
The market value of Arrowhead Pharmaceuticals is measured differently than its book value, which is the value of Arrowhead that is recorded on the company's balance sheet. Investors also form their own opinion of Arrowhead Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Arrowhead Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arrowhead Pharmaceuticals' market value can be influenced by many factors that don't directly affect Arrowhead Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arrowhead Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Arrowhead Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arrowhead Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.